Market Chatter: Genscript Biotech Defends Operations Amid Renewed U.S. Lawmaker Scrutiny

MT Newswires Live
Jun 03

Genscript Biotech (HKG:1548) defended its operations after renewed scrutiny from U.S. lawmakers over alleged national security concerns, the South China Morning Post reported Wednesday.

The company said it operates with transparency across its global markets and follows strict data security and intellectual property safeguards, according to the report.

The response came after two U.S. lawmakers reportedly sent a letter to the Federal Bureau of Investigation and the Office of the Director of National Intelligence for updated information regarding GenScript and its affiliates.

The lawmakers had made a similar request last year, citing concerns about potential links to China's biotechnology ambitions.

Shares of the life sciences firm were up over 14% in Wednesday afternoon trade.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10